SPONSOR
Fondazione Italiana Linfomi - ETS
Total Trials
3
Recruiting
3
Phases
Phase 3
Fondazione Italiana Linfomi - ETS is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Follicular Lymphoma, Diffuse Large B-Cell Lymphoma, Elderly Patients.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fondazione Italiana Linfomi - ETS
How many clinical trials has Fondazione Italiana Linfomi - ETS sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Fondazione Italiana Linfomi - ETS, of which 3 are actively recruiting participants. These trials cover conditions including Follicular Lymphoma, Diffuse Large B-Cell Lymphoma, Elderly Patients. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fondazione Italiana Linfomi - ETS research focus on?
Fondazione Italiana Linfomi - ETS clinical trials span Follicular Lymphoma, Diffuse Large B-Cell Lymphoma, Elderly Patients. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fondazione Italiana Linfomi - ETS clinical trial?
To participate in a Fondazione Italiana Linfomi - ETS trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fondazione Italiana Linfomi - ETS trials with current recruitment status updated daily.
Clinical Trials by Fondazione Italiana Linfomi - ETS
NCT05816850
Recruiting
Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial
Follicular Lymphoma
NCT05929222 Phase 3
Recruiting
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
Follicular Lymphoma
NCT04442412 Phase 3
Recruiting
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Diffuse Large B-Cell Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology